Showing results (11-20 of 198) with videos related to
Sort By:
Pageof 20
Blood|July 28, 2011
Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cellsYuko Suzuki, Hideki Yasui, Tomasz Brzoska, et al.Plos One|February 6, 2013
Binding of thrombin-activated platelets to a fibrin scaffold through α(IIb)β₃ evokes phosphatidylserine exposure on their cell surfaceTomasz Brzoska, Yuko Suzuki, Hideo Mogami, et al.Blood Advances|November 9, 2020
Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation systemYuko Suzuki, Hideto Sano, Liina Mochizuki, et al.FEBS Open Bio|July 16, 2016
Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cellsYuko Suzuki, Hideto Sano, Martyna Tomczyk, et al.Annals of Vascular Surgery|December 4, 2017
Ectopic Expression of PCSK9 by Smooth Muscle Cells Contributes to Aortic DissectionYasunori Iida, Hiroki Tanaka, Hideto Sano, et al.Current Drug Targets|October 6, 2022
COVID-19 and Thrombosis: Clinical AspectsTetsumei Urano, Atsushi Yasumoto, Kenji Yokoyama, et al.The Journal of Trauma|April 14, 2006
Nafamostat attenuated the impairment of fibrinolysis in animal sepsis model by suppressing the increase of plasminogen activator inhibitor type 1Tomasz Hryszko, Keisuke Inaba, Hayato Ihara, et al.The Journal of Biological Chemistry|July 28, 2006
Glucagon-like peptide 1 activates protein kinase C through Ca2+-dependent activation of phospholipase C in insulin-secreting cellsYuko Suzuki, Hui Zhang, Naoaki Saito, et al.Thrombosis Research|May 15, 2016
Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysisMartyna Tomczyk, Yuko Suzuki, Hideto Sano, et al.Current Drug Targets|January 24, 2018
Hypoperfusion of the Aortic Wall Secondary to Degeneration of Adventitial Vasa Vasorum Causes Abdominal Aortic AneurysmsHiroki Tanaka, Naoki Unno, Yuko Suzuki, et al.Pageof 20